Tuesday - August 4, 2026
Blood Test Guides Post-Surgical Immunotherapy for Muscle-Invasive Bladder Cancer
October 20, 2025
BOSTON, Massachusetts, Oct. 20 [Category: BizHospital] -- The Dana-Farber Cancer Institute issued the following news release:

* * *

Blood Test Guides Post-Surgical Immunotherapy for Muscle-Invasive Bladder Cancer

*

The Dana-Farber-co-led phase 3 IMvigor011 trial results show that periodic ctDNA screening after surgery can help guide a decision to begin adjuvant immunotherapy.

Patients with muscle-invasive bladder cancer who test p . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products